![Yaron Daniely](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yaron Daniely
Amministratore Delegato presso
Yissum Research Development Co. Ltd.
Profilo
Yaron Daniely is currently President & Chief Executive Officer at Yissum Research Development Co. Ltd. and a Member of the American Society of Hematology.
Formerly, Dr. Daniely was President & CEO at Starlet Derma Ltd. from 2007 to 2010, President & CEO at NanoCyte Ltd. from 2007 to 2010, Director at Alcobra Ltd. in 2017, Director at Bioblast Pharma Ltd., Director at Integra Holdings Ltd., Member at the National Institutes of Health, Member at the Weizmann Institute of Science, and Vice President-Business Development at Gamida Cell Ltd. from 2003 to 2007.
Education includes undergraduate studies at Florida International University, an MBA from Technion-Israel Institute of Technology in 2002, and a doctorate from New York University School of Medicine in 2000.
Posizioni attive di Yaron Daniely
| Società | Posizione | Inizio |
|---|---|---|
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
Yissum Research Development Co. Ltd.
 Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research invests in companies located in Israel. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Amministratore Delegato | - |
aMoon Ventures Y Sh Ltd.
 aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Investitore di Private Equity | 01/11/2019 |
Precedenti posizioni note di Yaron Daniely
| Società | Posizione | Fine |
|---|---|---|
Starlet Derma Ltd.
 Starlet Derma Ltd. Pharmaceuticals: MajorHealth Technology Develops a novel marine extracted microinjection system for efficient Intra-dermal penetration | Amministratore Delegato | 01/05/2010 |
NanoCyte Ltd.
 NanoCyte Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery platform technology solutions | Amministratore Delegato | 02/01/2010 |
| GAMIDA CELL LTD. | Corporate Officer/Principal | - |
Integra Holdings Ltd.
 Integra Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Direttore/Membro del Consiglio | - |
Bioblast Pharma Ltd.
 Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Direttore/Membro del Consiglio | - |
Formazione di Yaron Daniely
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Health Technology |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Yissum Research Development Co. Ltd.
Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research invests in companies located in Israel. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Florida International University
 Florida International University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technion-Israel Institute of Technology
 Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Starlet Derma Ltd.
Starlet Derma Ltd. Pharmaceuticals: MajorHealth Technology Develops a novel marine extracted microinjection system for efficient Intra-dermal penetration | Health Technology |
NanoCyte Ltd.
NanoCyte Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery platform technology solutions | Health Technology |
Integra Holdings Ltd.
Integra Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
aMoon Ventures Y Sh Ltd.
aMoon Ventures Y Sh Ltd. Investment ManagersFinance aMoon Ventures invests in companies located in Israel. The firm focuses on life-sciences, biopharma, digital health and medical technology companies. It provides financing for early and late stage capital requirements with an investment size of USD 10 - 30 million. The firm makes follow-on investments and also acts as lead investor. | Finance |
